These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11466860)

  • 1. [The treatment of hepatitis C].
    Färkkilä M
    Duodecim; 1997; 113(11):1061-8. PubMed ID: 11466860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
    Lucidarme D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic hepatitis C in active drug users.
    Davis GL; Rodrigue JR
    N Engl J Med; 2001 Jul; 345(3):215-7. PubMed ID: 11463020
    [No Abstract]   [Full Text] [Related]  

  • 4. Tuberculous sepsis during antiviral HCV triple therapy.
    Hametner S; Monticelli F; Kern JM; Schöfl R; Ziachehabi A; Maieron A
    J Hepatol; 2013 Sep; 59(3):637-8. PubMed ID: 23669285
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hepatitis C in intravenous drug users].
    Filoche B
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B252-6. PubMed ID: 12180298
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis C in France].
    Dhumeaux D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B133-7. PubMed ID: 12180280
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating intravenous drug users with hepatitis C infection: an opportunity in some settings.
    Chong VH; Jamaludin AZ; Jacob AP; Jalihal A
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1121. PubMed ID: 16957520
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia.
    Kikvidze T; Luhmann N; Avril E; Butsashvili M; Labartkava K; Etienne A; Le Pluart D; Inaridze I; Gamezardashvili A; Kharshiladze D; Bouscaillou J
    Int J Drug Policy; 2018 Feb; 52():16-19. PubMed ID: 29227878
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment for hepatitis C virus infection among current injection drug users in Australia.
    Matthews G; Kronborg IJ; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C.
    Chan J
    Dis Mon; 2014 May; 60(5):201-12. PubMed ID: 24863270
    [No Abstract]   [Full Text] [Related]  

  • 13. Disease progression and the risk factor analysis for chronic hepatitis C.
    Sinn DH; Paik SW; Kang P; Kil JS; Park SU; Lee SY; Song SM; Gwak GY; Choi MS; Lee JH; Koh KC; Yoo BC
    Liver Int; 2008 Dec; 28(10):1363-9. PubMed ID: 18710426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic hepatitis C in HIV-HCV coinfected patients].
    Gervais A
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B121-32. PubMed ID: 12180279
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is hepatitis C important for drug addicts?].
    Aavitsland P
    Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1623. PubMed ID: 19721475
    [No Abstract]   [Full Text] [Related]  

  • 16. [Short-time hepatitis C treatment and drug abuse].
    Kristensen Ø; Rysstad O; Gallefoss F
    Tidsskr Nor Laegeforen; 2009 Dec; 129(23):2498; author reply 2499. PubMed ID: 19997144
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology of hepatitis C virus infection in Australia.
    Dore GJ; MacDonald M; Law MG; Kaldor JM
    Aust Fam Physician; 2003 Oct; 32(10):796-8. PubMed ID: 14596073
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C management: the challenge of dropout associated with male sex and injection drug use.
    Lowry DJ; Ryan JD; Ullah N; Kelleher TB; Crowe J
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):32-40. PubMed ID: 21048503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis C and parenteral use of doping substances: an unknown route of transmission?].
    Coton T; Lightburn E; Faure P; Rey P; Dembele B; Debonne JM
    Gastroenterol Clin Biol; 2000 Mar; 24(3):375-6. PubMed ID: 10804354
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis.
    Sanyal AJ; Fontana RJ; Di Bisceglie AM; Everhart JE; Doherty MC; Everson GT; Donovan JA; Malet PF; Mehta S; Sheikh MY; Reid AE; Ghany MG; Gretch DR; Halt-C Trial Group
    Gastrointest Endosc; 2006 Dec; 64(6):855-64. PubMed ID: 17140886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.